IP Library Assignment 059935/0889
Patent Assignment
Reel/Frame 059935/0889

Assignment of Assignor's Interest

Recorded: 2022-05-17 Pages: 7
Assignors
WOLCHOK, JEDD DAVID
Executed: 2016-07-03
MERGHOUB, TAHA
Executed: 2016-07-14
SCHAER, DAVID
Executed: 2016-07-14
Assignee
MEMORIAL SLOAN KETTERING CANCER CENTER
1275 YORK AVENUE, NEW YORK, NEW YORK, 10065
Covered Property (1)
Anti-Ctla-4 Antibodies and Methods of Use Thereof
Application: 17/582,839 →
Publication: US 2022/0267443
Related Assignments (7)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Interest Mar 18, 2022
From: UROGEN PHARMA LTD.
To: BIOPHARMA CREDIT PLC
Reel/Frame 059302/0501 →
Assignment of Assignor's Interest May 17, 2022
From: VAN DIJK, MARC; MUNDT, CORNELIA ANNE
To: 4-ANTIBODY AG
Reel/Frame 059935/0837 →
Assignment of Assignor's Interest May 17, 2022
From: 4-ANTIBODY AG
To: AGENUS INC.
Reel/Frame 059935/0855 →
Assignment of Assignor's Interest May 17, 2022
From: WILSON, NICHOLAS STUART; SAVITSKY, DAVID ADAM; FINDEIS, MARK ARTHUR
To: AGENUS INC.
Reel/Frame 059935/0825 →
Assignment of Assignor's Interest May 17, 2022
From: RITTER, GERD
To: LUDWIG INSTITUTE FOR CANCER RESEARCH LTD
Reel/Frame 059935/0884 →
Amended and Restated Patent Security Agreement Mar 6, 2025
From: UROGEN PHARMA LTD.
To: BIOPHARMA CREDIT PLC [COLLATERAL AGENT]
Reel/Frame 070434/0319 →
Security Interest Mar 31, 2025
From: AGENUS, INC.
To: LIGAND PHARMACEUTICALS INCORPORATED
Reel/Frame 070680/0634 →